Benjamin L. Viglianti
Biochemistry, Genetics and Molecular Biology · University of Michigan
Publications
139
Citations
4,585
Est. group size
~10
Recurring co-author estimate
Active years
25
Publishing since 2002
Typically publishes in teams of ~9 · 5% small-team papers (≤3 authors) · across 37 venues
- Performance of Tc-Sestamibi Single-Photon Emission Computed Tomography/Computed Tomography for Characterizing Renal Masses: Combined Results From a Prospective Scan-and-Resect Trial and Clinical Experience
Open MIND · 2026
- Assessing PSMA Receptor Availability Using 68Ga-PSMA-11 PET/CT Following 177Lu-PSMA-617 Therapy Administration
Clinical Nuclear Medicine · 2026
- A Scoping Review of the Challenges and Future Perspectives in the Use of Alpha-Emitters for Metastatic Ovarian Cancer
Molecules · 2026
- Reply by Authors
The Journal of Urology · 2026
- Initial clinical experience with [177Lu]Lu-PNT2002 radioligand therapy in metastatic castration-resistant prostate cancer: dosimetry, safety, and efficacy from the lead-in cohort of the SPLASH trial
Frontiers in Oncology · 2025
- Determining PSMA-617 Mass and Molar Activity in Pluvicto Doses
Journal of Nuclear Medicine · 2025
- 177Lu-PSMA-617 Single-Photon Emission Computed Tomography/Computed Tomography Dosimetry and Radiobiological Models Demonstrate Decreasing Tumor-to-Kidney Dose Ratio With Successive Cycles
International Journal of Radiation Oncology*Biology*Physics · 2025
- Molecular imaging of neuroendocrine tumors: Current applications and future trends
Diagnostic and Interventional Imaging · 2025
- Quantitative Dynamic Contrast‐Enhanced Ultrasound Confirms Renal Obstruction
Journal of Ultrasound in Medicine · 2025
- Lack of effect of renal function on uptake of 99mTc-sestamibi in renal masses
Nuclear Medicine Communications · 2025
- Incoming novel radiotracer development: Fibroblast activation protein inhibitors for cancer diagnosis and treatment
Seminars in Roentgenology · 2025
- Theranostics 2.0: Target-driven, artificial intelligence-enabled cancer therapy across tumor types
Diagnostic and Interventional Imaging · 2025
- SNMMI/EANM/ACNM Procedure Standard/Procedure Guideline on the Use of Molecular Imaging for Renal Mass Characterization
Journal of Nuclear Medicine · 2025
- Molecular imaging for non-invasive risk stratification of renal masses
UNC Libraries · 2025
- Simultaneous Presentation of Post‐Transplant Lymphoproliferative Disorder (PTLD) and Acute Cellular Rejection (ACR) in a Liver Transplant Recipient: A Therapeutic Conundrum
Case Reports in Gastrointestinal Medicine · 2025
- Journal of Nuclear Medicine×8
- Clinical Nuclear Medicine×8
- International Journal of Radiation Oncology*Biology*Physics×7
- Biomedicine & Pharmacotherapy×4
- Diagnostic and Interventional Imaging×3
- Ekramy E. Sayedahmed
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Anna Bratasz
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Benjamin Curtis
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Amanda R. Welton
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Benjamin E. Draper
Biochemistry, Genetics and Molecular Biology · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile